Products

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC9979	PRX-08066 Featured	PRX-08066 is a selective 5-hydroxytryptamine receptor 2B (5-HT2BR, IC50= 3.4 nM) antagonist that causes selective vasodilation of pulmonary arteries.
DC21536	PS210 Featured	PS 210 is a potent, specific activator of PDK1 that target the PIF-binding pocket of PDK1, does not alter the activity of any of the 121 kinases (S6K, PKB/Akt or GSK3)..
DC21537	PS 423	PS 423 is a substrate-selective inhibitor of PDK1, inhibits the phosphorylation and activation of S6K without affecting the PKB/Akt signaling pathway in HEK293 cells, the prodrug of PS210.
DC23286	PS1	PS1 is a potent inhibitor of IAP family with IC50 of 36/96/33 nM for c-IAP1/c-IAP2/XIAP respectively..
DC21468	PS10	PS10 (PDK inhibitor PS10) is a novel potent and highly selective pyruvate dehydrogenase kinase (PDK) inhibitor.
DC7969	PS-1145 Featured	PS-1145 has been shown to be an IKK (IKB kinase) inhibitor.
DC23838	PS-432	PS-432 is an allosteric inhibitor of PKCι and PKCζ with IC50 of 16.9 and 18.5 uM, respectively.
DC22313	PS48 Featured	PS48 is a PDK1 (phosphoinositide-dependent protein kinase 1) activator which binds to the HM/PIF binding pocket rather than the ATP-binding site.
DC21538	PSB-12379 disodium	PSB-12379 is an α,β-Methylene-ADP (AOPCP) derivative, potent, selective ecto-5′-Nucleotidase (eN, CD73) inhibitor with Ki of 9.03/2.21 nM for rat/human recombinant eN.
DC21539	PSB-12431	PSB-12431 is an α,β-Methylene-ADP (AOPCP) derivative, potent, selective ecto-5′-Nucleotidase (eN, CD73) inhibitor with Ki of 9.2 nM for rat recombinant eN.
DC21540	PSB-12553	PSB-12553 is an α,β-Methylene-ADP (AOPCP) derivative, potent, selective ecto-5′-Nucleotidase (eN, CD73) inhibitor with Ki of 9.5 nM for rat recombinant eN.
DCAPI1432	Mupirocin	Pseudomonic Acid, also known as mupirocin, is an antibiotic isolated from Pseudomonas fluorescens which strongly inhibits protein and RNA synthesis. Inhibition of protein synthesis was reversed by isoleucine and Pseudomonic Acid was shown to inhibit isole
DC4121	PSI6130 Featured	PSI-6130(R 1656) is a Hepatitis C Virus Nucleoside Inhibitor. PSI-6130(R 1656) is useful for Antiviral agents.
DC6309	PSI6206 Featured	PSI-6206 is a selective inhibitor of hepatitis C virus (HCV).
DC10162	PSI-7409	PSI-7409 is the active 5′-triphosphate metabolite of PSI-7851. PSI-7851 is a selective and highly active nucleotide analog inhibitor of HCV.
DC6308	Sofosbuvir（PSI7977，GS-7977） Featured	PSI-7977 is an investigational nucleotide analog currently in Phase 2 for treatment of chronic HCV infection.
DC12162	PSMA-617 Featured	PSMA-617 is a high potent prostate-specific membrane antigen (PSMA) inhibitor, with a Ki of 0.37 nM.
DC7893	PSN632408	PSN632408 is an optimized agonist of GPR119 receptors that shows similar potency to OEA at both recombinant mouse and human GPR119 receptors, exhibiting EC50 values of 5.6 and 7.9 uM, respectively.
DC23683	PSN-GK1	PSN-GK1 is a potent, orally available Glucokinase (GK) activator with EC50 of 130 nM at 5 mM glucose (4.3-fold).
DC23654	Psora-4 Featured	Psora-4 is a potent and selective Kv1.3 potassium channel blocker with EC50 of 3 nM.
DC23199	Psoralidin Featured	Psoralidin possesses potent antidepressant-like, anti-inflammatory, anticancer and chemopreventive properties. Psoralidin is a dual inhibitor of COX-2 and 5-LOX
DC20513	PST-1	PST-1 is a photoswitchable inhibitor of microtubule with EC50 of 0.5 uM under 390 nm irradiation in the MDA-MB-231 human breast cancer cell lines.
DC20514	PST-1P	PST-1P is a photoswitchable inhibitor of microtubule with EC50 of 0.7 uM under 390 nm irradiation in the MDA-MB-231 human breast cancer cell lines.
DC10464	PT2385 Featured	PT2385 is an orally active, small molecule inhibitor of hypoxia inducible factor (HIF)-2alpha, with potential antineoplastic activity.
DC9811	PT2399 Featured	PT2399(PT=2399) is a novel HIF2α Antagonist.
DC8654	PTACH (NCH-51) Featured	PTACH (NCH-51) is a SAHA-based novel inhibitor of human HDAC. PTACH exerts potent growth inhibition against various human cancer cells, with EC50 values ranging from 1 to 10 μM.
DC7552	PTC-028 Featured	PTC-028 is an orally bioavailable compound that decreases BMI-1 levels by posttranslational modification
DC2005	PTC124 (Ataluren) Featured	PTC124 (Ataluren) is a potent nonsense mutation inhibitor with EC50 of ~0.1 μM.
DC7485	PTC-209 Featured	PTC-209 is a specific inhibitor for BMI-1 with IC50 of 0.5 uM in in both GEMS reporter and ELISA assays.
DC8495	PTC-209 hydrobromide Featured	PTC-209 is a specific inhibitor for BMI-1 with IC50 of 0.5 uM in in both GEMS reporter and ELISA assays.

Products

Customized Consultation X

Your information is safe with us. * Required Fields.